NCT04226755 (LUSA-HF) is a NA clinical trial of Sodium chloride in Heart Failure, sponsored by Ziekenhuis Oost-Limburg.

Who is sponsoring NCT04226755?

NCT04226755 is sponsored by Ziekenhuis Oost-Limburg.

What drugs are being tested in NCT04226755?

Interventions in NCT04226755: Sodium chloride.

What condition does NCT04226755 study?

NCT04226755 studies Heart Failure.

Is NCT04226755 still recruiting?

NCT04226755 is currently completed. Last updated 22 June 2023.

Last reviewed 2023-06-22 · How we verify

NCT04226755: LUSA-HF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Liberal Use of Sodium in Ambulatory Heart Failure

Completed NA Last updated 22 June 2023

What this trial tests

NA trial testing Sodium chloride in Heart Failure in 31 participants. Completed in 30 June 2022.

Timeline

1 June 2020

Primary endpoint
30 June 2022

30 June 2022

Quick facts

Lead sponsor	Ziekenhuis Oost-Limburg
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	basic science
Enrollment	31
Start date	1 June 2020
Primary completion	30 June 2022
Estimated completion	30 June 2022
Sites	1 location across Belgium

Drugs / interventions tested

Sodium chloride (Sodium Chloride) — full drug profile →

Conditions studied

Heart Failure — all drugs for Heart Failure →

Sponsor

Ziekenhuis Oost-Limburg — full company profile →

Who can join

18 and older, any sex, with Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigates the effects of an increased sodium intake in heart failure patients with reduced ejection fraction and age-matched volunteers without heart failure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Sodium chloride

Trials testing the same drug.

NCT06872060 — The Effects of Glucagon on Renal Regional Blood Flow in Humans Measured by Magnetic Resonance. · NA · not yet recruiting
NCT06305182 — Metreleptin in Anorexia Nervosa · Phase 2 · recruiting
NCT05564130 — Bicarbonate for In-Hospital Cardiac Arrest · Phase 4 · active not recruiting
NCT06494007 — Role of IV Calcium to Prevent Diltiazem-related Hypotension · Phase 4 · completed
NCT05582798 — Bronchiectasis Alpha-1 Augmentation Trial- Modulating Airway Neutrophil Function · Phase 4 · completed

Other recruiting trials for Heart Failure

Currently open trials in the same condition.

NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting

Other Ziekenhuis Oost-Limburg trials

Trials by the same sponsor.

NCT07281534 — Test-Retest Reliability of Cardiopulmonary Exercise Testing With Echocardiography · NA · recruiting
NCT07123818 — AI for Detection of Brain Aneurysm: Low-cost Opportunistic Screening · NA · active not recruiting
NCT06994091 — Imaging Comparison for the Preoperative Planning and Diagnosis of DIE: a Multicenter Retrospective Study. · not yet recruiting
NCT06185608 — The Effects of Various Concentrations of Ropivacaine on the Onset and Duration of Ankle Blocks · NA · recruiting
NCT06810479 — A Study Comparing Two Mandibular Advancement Devices in the Treatment of Sleep Apnea · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04226755 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ziekenhuis Oost-Limburg
Last refreshed: 22 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04226755.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing